Cargando…
Exo-miRNAs as a New Tool for Liquid Biopsy in Lung Cancer
Lung cancer is the predominant cause of cancer-related deaths. The high mortality rates are mainly due to the lack of diagnosis before the cancer is at a late stage. Liquid biopsy is a promising technique that could allow early diagnosis of lung cancer and better treatment selection for patients. Ce...
Autores principales: | Fortunato, Orazio, Gasparini, Patrizia, Boeri, Mattia, Sozzi, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627875/ https://www.ncbi.nlm.nih.gov/pubmed/31242686 http://dx.doi.org/10.3390/cancers11060888 |
Ejemplares similares
-
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
por: Mensah, Mavis, et al.
Publicado: (2017) -
MiRNAs as Players in Rhabdomyosarcoma Development
por: Gasparini, Patrizia, et al.
Publicado: (2019) -
MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature
por: Fortunato, Orazio, et al.
Publicado: (2016) -
Therapeutic Use of MicroRNAs in Lung Cancer
por: Fortunato, Orazio, et al.
Publicado: (2014) -
Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients
por: Fortunato, Orazio, et al.
Publicado: (2014)